Interaction between natural compounds and human topoisomerase I

被引:42
|
作者
Castelli, Silvia [1 ]
Coletta, Andrea [1 ]
D'Annessa, Ilda [1 ]
Fiorani, Paola [2 ]
Tesauro, Cinzia [1 ]
Desideri, Alessandro [1 ]
机构
[1] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy
[2] CNR, Natl Res Council, Inst Translat Pharmacol, I-00133 Rome, Italy
关键词
enzymatic catalytic steps; inhibition mechanism; natural compounds; topoisomerase I; CONJUGATED EICOSAPENTAENOIC ACID; DNA TOPOISOMERASE; CAMPTOTHECIN RESISTANCE; LEISHMANIA-DONOVANI; LUOTONIN-A; ANTITUMOR PROPERTIES; CYTOTOXIC ACTIVITY; SINGLE MUTATION; BETA-LAPACHONE; CANCER-CELLS;
D O I
10.1515/hsz-2012-0240
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Eukaryotic topoisomerase I (Top1) is a monomeric enzyme that catalyzes the relaxation of supercoiled DNA during important processes including DNA replication, transcription, recombination and chromosome condensation. Human Top1 I is of significant medical interest since it is the unique cellular target of camptothecin (CPT), a plant alkaloid that rapidly blocks both DNA and RNA synthesis. In this review, together with CPT, we point out the interaction between human Top1 and some natural compounds, such us terpenoids, flavonoids, stilbenes and fatty acids. The drugs can interact with the enzyme at different levels perturbing the binding, cleavage, rotation or religation processes. Here we focus on different assays that can be used to identify the catalytic step of the enzyme inhibited by different natural compounds.
引用
收藏
页码:1327 / 1340
页数:14
相关论文
共 50 条
  • [21] Molecular Interaction between Escherichia Coli Topoisomerase I and pBAD/Thio Supercoiled Plasmid DNA
    Tiwari, Purushottam
    Annamalai, Thirunavukkarasu
    Cheng, Bokun
    Narula, Gagandeep
    Wang, Xuewen
    Tse-Dinh, Yuk-Ching
    He, Jin
    Darici, Yesim
    BIOPHYSICAL JOURNAL, 2015, 108 (02) : 398A - 398A
  • [22] Purification and characterization of human topoisomerase I mutants
    Jensen, AD
    Svejstrup, JQ
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 236 (02): : 389 - 394
  • [23] Topoisomerase I in Human Disease Pathogenesis and Treatments
    Li, Min
    Liu, Yilun
    GENOMICS PROTEOMICS & BIOINFORMATICS, 2016, 14 (03) : 166 - 171
  • [24] Reconstitution of human topoisomerase I by fragment complementation
    Stewart, L
    Ireton, GC
    Champoux, JJ
    JOURNAL OF MOLECULAR BIOLOGY, 1997, 269 (03) : 355 - 372
  • [25] Topoisomerase I in Human Disease Pathogenesis and Treatments
    Min Li
    Yilun Liu
    Genomics,Proteomics & Bioinformatics, 2016, (03) : 166 - 171
  • [26] Domains of human topoisomerase I and associated functions
    Champoux, JJ
    PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY, VOLUME 60, 1998, 60 : 111 - 132
  • [27] A role for the amino terminus of human topoisomerase I
    Haluska, P
    Rubin, EH
    ADVANCES IN ENZYME REGULATION, VOL 38, 1998, 38 : 253 - 262
  • [28] DNA topoisomerase I, DNA topoisomerase IIα, and DNA topoisomerase IIβ as markers for human tumors.
    Foglesong, PD
    Reyes, A
    Breitenstein, H
    Martin, L
    D'Andrea, MR
    Connolly, RT
    Szcykalski, LM
    FASEB JOURNAL, 1998, 12 (04): : A197 - A197
  • [29] Molecular docking studies of the interaction between propargylic enol ethers and human DNA topoisomerase IIα
    Silveira-Dorta, Gaston
    Sousa, Ines J.
    Rios-Luci, Carla
    Martin, Victor S.
    Fernandes, Miguel X.
    Padron, Jose M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (19) : 5382 - 5384
  • [30] Interaction between human serum esterases and environmental metal compounds
    Hernandez, Antonio F.
    Gil, Fernando
    Leno, Esther
    Lopez, Olga
    Rodrigo, Lourdes
    Pla, Antonio
    NEUROTOXICOLOGY, 2009, 30 (04) : 628 - 635